- Release Date: 13/02/17 14:26
- Summary: Study Results - BLIS K12 Probiotic- Strep Throat
- Price Sensitive: No
- Download Document 208.49KB
- Forums
- NZX - By Stock
- BLT
- Ann: Study Results - BLIS K12 Probiotic- Strep Throat
BLT
blis technologies limited
Add to My Watchlist
0.00%
!
1.7¢

Ann: Study Results - BLIS K12 Probiotic- Strep Throat
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online